Autonomic dysfunction in Parkinson disease and animal models
- 2 January 2019
- journal article
- review article
- Published by Springer Nature in Clinical Autonomic Research
- Vol. 29 (4) , 397-414
Abstract
Parkinson disease has traditionally been classified as a movement disorder, despite patients’ accounts of diverse symptoms stemming from impairments in numerous body systems. Today, Parkinson disease is increasingly recognized by clinicians and scientists as a complex neurodegenerative disorder featuring both motor and nonmotor manifestations concomitant with pathology throughout all major branches of the nervous system. Dysfunction of the autonomic nervous system, or dysautonomia, is a common feature of Parkinson disease. It produces signs and symptoms that severely affect patients’ quality of life, such as blood pressure dysregulation, hyperhidrosis, and constipation. Treatment options for dysautonomia are limited to symptom alleviation because the cause of these symptoms and Parkinson disease overall are still unknown. Animal models provide a platform to interrogate mechanisms of Parkinson disease-related autonomic nervous system dysfunction and test novel treatment strategies. Several animal models of Parkinson disease are available, each with different effects on the autonomic nervous system. This review critically analyses key dysautonomia signs and symptoms and associated pathology in Parkinson disease patients and relevant findings in animal models. We focus on the cardiovascular system, adrenal medulla, skin/thermoregulation, bladder, pupils, and gastrointestinal tract, to assess the contribution of animal models to the understanding of Parkinson disease autonomic dysfunction.Keywords
Funding Information
- National Institutes of Health (P51OD011106)
- National Institutes of Health (R24OD019803, F31HL136047)
This publication has 200 references indexed in Scilit:
- Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in miceScientific Reports, 2012
- Cardiovascular dysautonomia in Parkinson disease: From pathophysiology to pathogenesisNeurobiology of Disease, 2012
- A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (“Line 61”) MiceNeurotherapeutics, 2012
- Gastrointestinal Dysfunction in a Parkinson’s Disease Rat Model and the Changes of Dopaminergic, Nitric Oxidergic, and Cholinergic Neurotransmitters in Myenteric PlexusJournal of Molecular Neuroscience, 2011
- PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart functionProceedings of the National Academy of Sciences, 2011
- Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disordersActa Neuropathologica, 2010
- Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's diseaseExperimental Neurology, 2009
- Bowel movement frequency in late‐life and substantia nigra neuron density at deathMovement Disorders, 2009
- Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's diseaseExperimental Neurology, 2007
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998